#103 - Looking back on the first 99 episodes: Strong Convictions, Loosely Held

Episode Summary

Executive Summary: Episode 100 of The Drive is a retrospective on how Peter Atiyah’s views have evolved across medicine, training, and lifestyle. Using “strong convictions loosely held” as the theme, Peter and Bob revisit changes in thinking on metformin, rapamycin, zone 2 training, deadlifts, aspirin for flight DVT prevention, generics, omega-3s, saying no, and even getting a dog—showing how new data and lived experience reshape behavior.

Main Topics: Strong convictions loosely held (Priority: 5/5): The episode frames scientific and personal growth as a willingness to revise beliefs when new evidence or experience emerges, especially in medicine where changing one’s mind is a strength rather than a weakness. Metformin and longevity (Priority: 5/5): Peter explains why he stopped taking metformin after noticing elevated lactate and reconsidering its role as a longevity drug, now reserving it mainly for patients who need glucose/insulin control. Rapamycin and mTOR (Priority: 5/5): He describes a gradual shift toward confidence in rapamycin’s potential benefits, while emphasizing uncertainty about dosing, cycling, and biomarkers for efficacy and safety. Zone 2 training and aerobic health (Priority: 4/5): Peter says zone 2 became a major missing piece in his training, valued for mitochondrial, metabolic, and neurotrophic benefits, and because it is sustainable and enjoyable. Strength training, deadlifts, and movement quality (Priority: 4/5): Deadlifting is reframed from a maximal-load exercise to a diagnostic and preparatory tool that improves biomechanics, spinal positioning, and daily function. Lifestyle and decision-making changes (Priority: 4/5): The conversation covers unexpected shifts in views on getting a dog, using aspirin for flight-related clot prevention, generic drugs, omega-3s, and the importance of saying no to protect time and focus. Podcasting as a craft and retrospective (Priority: 3/5): Peter reflects on how the podcast has become a vehicle for learning, humility, and mastery, and highlights memorable episodes and guests that shaped his thinking.

Key Arguments: Scientific and medical beliefs should be revisable; changing one’s mind is a feature of good medicine, not a flaw. Metformin may be more useful in metabolically ill patients than in healthy people seeking longevity benefits; Peter stopped taking it after observing higher lactate and lower zone 2 efficiency. Rapamycin appears promising enough that Peter now uses it, but the field still lacks ideal biomarkers and clarity on optimal cycling/dosing. Zone 2 training fills an important gap in Peter’s regimen by improving metabolic health, mitochondrial function, and long-term sustainability. Deadlifts are valuable less as a strength test and more as a movement-quality audit that reinforces proper spinal mechanics and daily-life function. Aspirin is not well supported for preventing DVT on flights; other agents/supplements may have stronger evidence, though practical use remains an issue. Not all generics may be equivalent in practice; after Catherine Eban’s episode, the clinic became more selective about manufacturers and often prefers branded drugs. EPA and DHA should be treated as potent interventions, with EPA especially strong for cardiovascular risk reduction; omega-6 remains controversial and warrants deeper review. Learning to say no is essential because every yes displaces something else, and protecting time improves focus and quality of work. The podcast itself has become a long-term learning system, with each episode helping refine hypotheses and improve practice. Getting a dog changed Peter’s view from strong resistance to appreciation for the intangible benefits of companionship and forced stillness.

Data Points: Podcast episode number: 100 - This is the centennial episode of The Drive. Metformin use duration: About 7 years - Peter says he had been taking metformin since around 2011 until stopping after reassessing it in late 2018/2019. Metformin reassessment period: 4-6 months - He experimented with dose timing and reduction before stopping it altogether. Zone 2 training volume: 3-4 hours per week - Peter says he spends this amount of time on zone 2 biking and uses it to listen to podcasts/audiobooks. Deadlift frequency: At least 2 times per week, often 3 - He describes frequent deadlifting as part of his movement-quality practice. Deadlift load: 350-375 lb trap bar; about 185 lb straight bar - He notes he usually deadlifts lighter loads now, focusing on form rather than maximal weight. Deadlift checklist duration: 10-15 minutes - He says his preparation routine before deadlifting is short and repeatable. Archery target distance: 20 yards - Indoor target archery is described as shooting at a quarter-sized target from 20 yards. Perfect archery round: 60 shots / 300 points - He explains that a perfect indoor round would require 60 shots all in the X-ring. High school GPA: 1.44 - Peter cites his own poor academic performance in high school as part of his story about mastery and effort. Dog age at adoption: 4 weeks - Molly, the puppy, was adopted four weeks before the recording. Podcast show notes and membership: Monthly AMAs, private feed, Qualies, discounts - These are listed as membership benefits at the end of the episode.

Pivotal Quotes: "Strong convictions loosely held." — Peter Atiyah: The episode’s central theme and title, describing the ideal scientific mindset. "What you do in science is you make a hypothesis, and then you try to shoot yourself down." — Bob Kaplan: Bob summarizes the scientific method as a process of actively challenging one’s own ideas. "I reserve metformin prescriptions for patients who obviously are in need of it from the standpoint of glucose and insulin regulation, but I don't view it really as a pro longevity agent yet." — Peter Atiyah: Peter explains his updated position after stopping metformin himself.

Implications: Listeners are encouraged to treat health advice as provisional, prioritize evidence over dogma, and build routines that support long-term function, focus, and adaptability. The episode also signals future deep dives on rapamycin, omega-6s, and other evolving topics.